Abstract
With the advent of molecular cloning techniques in the past decade, a large number of novel gene products with unknown functions have been identified in the brain. For instance, an explosive growth has occurred in the discovery of many new receptor subtypes or receptors for most neurotransmitters. However, the lack of truly selective ligands for each of these new receptors makes it impossible to investigate their functional roles. Establishing the precise function of the newly identified receptors is an essential step for the understanding of their cellular mechanisms which may be pivotal in important neurophysiological processes and may lead to understanding of neurological or psychiatric diseases and/or their treatement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akabayashi, A., Wahlestedt, C, Alexander, J T, and Leibowitz, S F. (1994) Specific inhibition of neuropeptide Y synthesis in arcuate neucleus by antisense ohgonucleotides suppresses feeding behavior and insuhn secretion Mol Brain Res 21, 55–61
Apostolakis, E. M, Garai, J, Fox, C, Smith, C L, Watson, S J, Clark, J H, and O’Malley, W (1996) Dopaminergic regulation of progesterone receptors bram D5 dopamine receptors mediate induction of lordosis by Dl-like agonists in rats. J Neurosci 16, 4823–4834
Bencsics, C, Wachtel, S R, Milstein, S, Hatakeyama, K, Becker, J B, and Kang, U J (1996) Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts J Neurosci. 16, 4449–4456
Bergan, R, Connell, Y, Fahmy, B, Kyle, E, and Neckers, L (1994) Aptameric inhibition of p210bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined seuqnce and backbone structure Nucleic Acids Res 22, 2150–2154
Berhow, M T, Hiroe, N, and Nestler, E J (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine J Neurosci 16, 4707–4715.
Brysh, W, Rifai, A, Tischmeyer, W., and Schlingensiepen, K-H (1996) Antisense-mediated inhibition of protein synthesis rational drug design, pharmacokinetics, intracerebral application, and organ uptake of phosphorothioate oligodeoxynucleotides, in Methods tn Molecular Medicine Antisense Therapeutics, (Agrawal, S, ed ), Humana, Totowa, NJ, pp 159–182
Casticas, M Osen-Sand, A, Staple, J K, Jones, K A, Ayala, G, Knowles, J. Grennmgloh, C, Pich, E M., and Casticas, S (1996) Antisense blockade of expression SNAP-25 m vitro and in vivo, in Methods in Molecular Medicine Antisense Therapeutics, (Agrawal, S., ed.), Humana Press, Totowa, NJ, pp 57–86
Chavany, C, Connell, Y, and Neckers, L (1995) Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Mol Pharmacology 48, 738–746
Chiasson, B. J, Amstrong, J N, Hooper, M. L., Murphy, P. R, and Robertson, H A (1994) The application of antisense oligonucleotides technology to the brain, some pitfalls Cell Mol Neurobiol 14, 507–521.
Chiasson, J. B, Hong, M, Hooper, M L, Amstrong, J N, Murphy P. R, and Robertson, H. A (1996) Antisense therapeutics in the central nervous system The inducion of c-fos, in Methods in Molecular Medicine Antisense Therapeutics, (Agrawal, S, ed ), Humana, Totowa, NJ, pp 225–245
Cohen, J S (1991) Oligonucleotides as therapeutic agents Pharmac Ther 52, 211–225
Gao, W-Y., Han, F.-S, Storm, C, Egan, W, and Cheng, Y-C 1992. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology Mol Pharmacology 41, 223–229
Georgieva, J, Heihg, M, Nylander, I, Herrera-Marschitz, M, and Trerenius, L (1995) In vivo antisense inhibition of prodynorphin expression in rat striatum. dose-dependence and sequence specificity. Neurosci. Lett 92, 69–71
Gerlai, R. (1996) Gene-targeting studies of mammalian behavior, is it the muta tion or the background genotype? Trends Neurosci 19, 177–181
Heilig, M, Engel, J A, and Soderpalm B (1993) C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine Eur J Pharmacol 236, 339–340
Heilig, M (1994) Antisense technology prospects for treatment of neuropsychiatnc disorders. CNS Drugs 1, 405–409
Hélène, C and Toulme, J-J (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids Biochemica Biophysica Acta 1049, 99–125.
Hunter, A J, Leslie, R. A., Gloger, I. S., and Lawrence, M. (1995) Probing the function of novel genes in the nervous system’ is antisense the answer? Trends Neurosci 18, 329–331.
Karle, J and Nielsen, M (1995) Modest reduction of benzodiazepine binding in rat brain in vivo induced by antisense oligonucleotide to GABAA receptor γ2Subunit subtype. Eur J Pharmacol 291, 439–441.
Korte, S. M., De Kloet, E R, Buwalda, B., Bouman, S D., and Bohus, B. (1996) Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Euro J Pharmacol 301, 19–25
Lai J., Bilsky, E J, Rothman, R B., and Porreca, F (1994) Treatment with antisense oligodeoxynucleotide to opiod 8 receptor selectively inhibits δ2-agonist antinociception NeuroReport 5, 1049–1052
Landgraf, R. Gerstberger, R, Montkowski, A., Probst, J. C, Wotjak, C. T, Holsboer, F., and Engelmann, M (1995) VI vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J Neurosci 15, 4250–4258
Lima, W F, Moma, B P, Ecker, D J, and Freier, S M (1992) Implication of RNA structure on antisense oligonucleotide hybridization kinetics Biochemistry 31, 12, 055–12, 061
Maclntyre, T L, Andrews, M, and Roberts, D C S (1995) Microinjection of dopamine D2 receptor antisense oligonucleotides disrupts cocaine selfadmmistration in the rat. Soc Neurosci Abst 288 2
McCarthy, M M, Masters, D B, Rimvall, K, Schwartz-Giblin, S., and Pfaff, D W (1994) Intracerebral administration of antisense oligodeoxynucleotides to GAD65 and GAD67 mRNA modulate reproductive behavior in the female rat Brain Res 636, 209–220
Meeker, R, LeGrand, G, Ramirez, J, Smith, T, and Shih, Y-H (1995) Antisense vasopressin oligonucleotides uptake, turover, distrubution, toxicity and behavioral effects J Neuroendocrinal 7, 419–428
Neckers, L M (1993) Cellular internalization of oligodeoxynucleotides, in Antisense Research and Applications, (Crooke, S T and Lebleu, B, eds ), CRC, Boca Raton, PL, pp 451–456
Nissbrandt, H, Ekman, A., Eriksson, E, and Heilig, M (1995) Dopamine D3 receptor antisense influences dopamine synthesis in rat brain NeuroReport 6, 573–576
Ogawa, S, Olazábal, U E, Parhar, I S, and Pfaff, D W (1994) Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat J Neurosci 14, 1766–1774
Pasternak, G W and Standifer, K M 1995 Mapping of opioid receptor using antisense oligodeoxynucleotides correlating their molecular biology and pharmacology Trends Pharmacol Sci 16, 344–350
Paxinos, G and Waston, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed, Academic, London
Peyman, A, Ryte, A, Helsberg, M., Kretzschmar, G, Mag, M., and Uhlmann, E (1995) Enhanced cellular uptake of G-rich oligodeoxynucleotides Nucleosides Nucleotides 14, 1077–1081
Plata-Salamán, C R, Wilson, C D, Sonti, G, Borkoski, J P., and ffrench-Mullen, J M. H, (1995) Antisense oligodeoxynucleotides to G-protein a-subunit subclasses identify a transductional requirement for modulation of normal feeding dependent on GσOA subunit Mol Brain Res 33. 72–78
Pollio, G, Xue, P., Zanisi, M, Nicolin, A, and Mggi, A (1993) Antisense oligonucleotide blocks progesterone-mduced lordosis behavior m ovarieectomized rats Mol Brain Res 19, 135–139
Silvia, C. P., King, G R., Lee, T H, Xue, Z-Y, Caron, M G, and Ellinwood, E H (1994) Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine Mol. Pharmacol 46, 51–57
Skutella, T, Probst, J C, Jinkowski, G F, Holsboer, F, and Spanagel, R (1994) Ventral tegmental area (VTA) injection of tyrosine hydroxylase phosphorothioate antisense oligonucleotide supress operant behavior in rats. Neurosci Lett 167, 55–58
Standaert, D G, Testa, C M, Rudolf, G D, and Hoolingsworth Z R (1996) Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation J Pharmacol Exp Ther 276, 342–352
Standifer, K M, Jenab, S, Su, W Chien, C-C. Pan, Y-X, Inturnsi, C. E, and Pasternak, G W (1995) Antisense oligodeoxynucleotides to cloned δ receptor DOR-1’ uptake, stability, and regulation of gene expression J Neurochem 65, 1981–1987
Stein, C A and Krieg, A. M (1994) Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides Antisense Res Dev. 4, 67–69
Sun, B.-C, Zhang, M, Ouagazzal, A, Tepper, J. M, and Creese, I (1996) Dopamine receptor function an analysis utilising antisense knockout in vivo, in Pharmacological Regulation of Gene Expression in the CNS, (Merchant, K. M, ed.), CRC Press, Boca Raton, FL, pp 51–77
Szabó, G, Nunley, K. R, and Hoffman, P L (1996) Antisense oligonucleotide to c-fos blocks the ability of arginine vasopressin to maintain ethanol toler ance Eur J Pharmacol 306, 67–72
Szklarczyk, A and Kaczmarek, L, (1995) Antisense oligodeoxynucleotides sta bility and distribution after intracerebral injection into rat brain J Neurosci Methods 60, 181–187.
Tepper, J. M., Sun, B-C, Martin, L P., and Creese, I (1997) Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockoudown in vivo J Neurosci 17, 2519–2530
Wada, J, Lm, Z, Alvares, K, Kumar, A, Wallner, E, Makino, H, and Kanwar, Y (1993) Cloning of cDNA for asubunit of mouse insuline-like growth factor I receptor and the role of the receptor in metanephnc development Proc Natl Acad Sci USA 90, 10360–10364
Wagner, R W, Matteucci, M D, Grant, D, Huang, T, and Froehler, B C (1996) Potent and selective inhibition of gene expression by antisense heptanucleotide Nature Biotech 14, 840–844
Wahlestedt, C Golanov, E, Yamamoto, S, Yee, F, Ericson, H, Yoo, H., Inturnsi, C. E, and Reis, D J. (1993a) Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infractions Nature 363, 260–263
Wahlestedt, C, Pich, E M, Koob, G F, Yee, F, and Heihg, M. (1993b) Modulation of anxiety and neuropeptide Y-Yl receptors by antisense oligodeoxynucleotides. Science 259, 528–531
Wahlestedt, C (1994) Antisense oligonucleotide strategies in neuropharmacology Trends Pharmacol Sci 15, 42–46
Weiss, B, Zhou, L.-W., Zhang, S-P., and Qin, Z-H (1993) Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA Neuroscience 55, 607–612
Weiss, B, Zhou, L-W., and Zhang, S.-P. (1996) Dopamine antisense oligodeoxynucleotides as potential novel tools for studying drug abuse, in Antisense Strategies for the Study of Receptor Machanisms, (Raffa, R B and Porreca, F, eds), R. G Landes, Austin, TX, pp 71–91
Whitesell, L., Geselowitz, D., Chavany, C, Fahmy, B, Walbridge, S, Alger, J. R, and Neckers, L, M (1993) Stability, clearance, and disposition of mtraventricularly adminstered oligodeoxynucleotides implications for therapeutic application within the central nervous system.Proc Natl Acad Sci USA 90, 4665–4669.
Widnell, K L, Self, D. W, Lane, S B., Russell, D. S., Vaidya, V A, Miserendino, M J D, Rubin, C S, Duman, R. S, and Nestler, E. J (1996) Regulation of CREB expression in vivo evidence for functional role in morphine action in the nucleus accumbens J Pharmacol Exp Ther 276, 306–315.
Yoon, S K., Lois, C, Alvirez, M, Alvarez-Buylla, A, Falck-Pedersen, E, and Chao, M V. (1996) Adenovirus-mediated gene delivery into neuronal precursors of adult mouse brain Proc Natl Acad Sci USA 93, 11, 974–11, 979
Zhang, M and Creese, I (1993) Antisense oligodeoxynucleotide reduces reduces brain dopamine D2 receptors behavioral correlates Neurosci Lett. 161, 223–226
Zhang, M, Ouagazzal, A, Sun, B-C, and Creese, I (1996) Regulation of motor behavior by dopamine receptor subtypes an antisense knockout approach, in The Dopamine Receptors, (Neve, K and Neve, R, eds.), Humana, Totowa, NJ, pp 425–455
Zhang, S.-P, Zhou, L-W, Morabito, M, Lm, R C S, and Weiss, B (1996) Uptake and distribution of fluorescein-labeled D2 dopamine receptor antisense oligodeoxynucleotide m mouse brain J Mol Neurosci 7, 13–28
Zhao, T-J., Rosenberg, H. C, and Chiu, T H (1996) Treatment with an antisense oligodeoxynucleotide to the GABA A receptor γ2 subunit increases convulsive threshold for β-CCM, a benzodiazepine ‘inverse agonists’, in rats Eur J Pharmacol 306, 61–66.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc.
About this protocol
Cite this protocol
Ouagazzal, AM., Tepper, J.M., Creese, I. (1998). Antisense Oligodeoxynucleotide Technology. In: In Vivo Neuromethods. Neuromethods, vol 32. Humana Press. https://doi.org/10.1385/0-89603-511-5:295
Download citation
DOI: https://doi.org/10.1385/0-89603-511-5:295
Publisher Name: Humana Press
Print ISBN: 978-0-89603-511-9
Online ISBN: 978-1-59259-637-9
eBook Packages: Springer Protocols